Status | Study |
Recruiting |
Study Name: Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors Condition: Malignant Peripheral Nerve Sheath Tumors Date: 2017-04-13 |
Not yet recruiting |
Study Name: Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors Condition: Peripheral Nerve Tumors Date: 2016-11-21 Interventions: Drug: CPI-0610 Optional tu |
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
Recruiting |
Study Name: Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery Condition: Metastatic Malignant Peripheral Nerve Sheath Tumor Neurofibroma Date: 2016-02-25 Interventions: Procedure: Computed Tomography |
Recruiting |
Study Name: A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Condition: Malignant Peripheral Nerve Sheath Tumour (MPNST) Date: 2016-02-04 Interventions: Drug: Pembrolizumab Other Name: Keytruda |
Recruiting |
Study Name: Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma Condition: High Grade Sarcoma Metastatic Leiomyosarcoma Metastatic Date: 2015-11-09 Interventions: Drug: Pazopanib Hydrochloride |
Recruiting |
Study Name: PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Condition: Sarcoma Malignant Peripheral Nerve Sheath Tumors Date: 2015-10-21 Interventions: Drug: PLX3397 PLX3397 is a sel |
Recruiting |
Study Name: Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Condition: Sarcoma, Soft Tissue Soft Tissue Sarcoma Undifferentiated Date: 2015-10-12 Interventions: Drug: Dexrazoxane Other Names: |
Active, not recruiting |
Study Name: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma Condition: Pleuropulmonary Blastoma Recurrent Malignant Peripheral Nerve Sheath T Date: 2015-05-20 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Condition: Neurofibromatosis MPNST Date: 2014-08-06 Interventions: Procedure: MRI, FDG-PET/CT scans |